Abstract
The study examined differential effects of preoperative biomarkers (cotisol, C-reactive protein/CRP, and interleukin-6/IL-6) on postoperative symptoms in mental health (depressed mood, anxiety and hostility) 1 month following open-heart surgery, controlling for known predictors. Preoperative and postoperative interviews were conducted on 162 patients. Peripheral venous blood samples were collected between 8 and 10 a.m. prior to surgery. Cardiac indices were obtained from the Society of Thoracic Surgeons’ national database. Preoperative anxiety contributed to all outcomes about 1 month postoperatively. Patients with high preoperative plasma IL-6 used more avoidant coping and experienced greater depressed mood. Patients with increased plasma CRP and with hope were less depressed. Elevated plasma cortisol predicted hostility. Finally, medical comorbidities predicted anxiety and hostility. The combination of anxiety and stress-sensitive biomarkers may be one way to predict postoperative symptoms following open-heart surgery. Our findings emphasize the importance of investigating the mind–body interplay to come up with better interventions.
Similar content being viewed by others
References
Ai, A. L., Appel, H., & Pasic, J. (2008). Mental health comorbidity in cardiovascular disease: Implications for interdisciplinary intervention. In L. Sher (Ed.), Psychological factors and cardiovascular disorders: The role of psychiatric pathology and maladaptive personality features (pp. 311–338). Hauppau, NY: Nova Science Publishers.
Ai, A. L., Hall, D., & Pargament, K. (2012). Posttraumatic growth in patients who survived cardiac surgery: The predictive and mediating roles of faith-based factors. Journal of Behavioral Medicine, 35.
Ai, A. L., Park, C., Huang, B., Rodgers, W., & Tice, T. N. (2007). Psychosocial mediation of religious coping: A prospective study of short-term psychological distress after cardiac surgery. Personality and Social Psychology Bulletin, 33, 867–882.
Ai, A. L., Seymour, E. M., Kronfol, Z., & Bolling, S. (2011). Moot states, coping factors, and interleukin-6 are related to psychiatric symptoms following cardiac surgery. Biological Psychiatry and Psychopharmacology, 13, 2–9.
Ai, A. L., Seymour, E. M., Tice, N. T., Kronfol, Z., & Bolling, S. F. (2009). Spiritual struggle related to plasma interleukin-6 prior to cardiac surgery. Psychology of Religion and Spirituality, 1, 112–128.
Anisman, H., Hayley, S., Turrin, N., & Merali, Z. (2002). Cytokines as a stressor: implications for depressive illness. International Journal of Neuropsychopharmocology, 5, 357–373.
Bankier, B., Barajas, J., Martinez-Rumayor, A., & Januzzi, J. L. (2009). Association between major depressive disorder and C-reactive protein levels in stable coronary heart disease patients. Journal of Psychosomatic Research, 66, 189–194.
Bjorntorp, P., & Rosmond, R. (2000). The metabolic syndrome—a neuroendocrine disorder? British Journal of Nutrition, 83, S49–S57.
Bremner, J. D., Cheema, F. A., Ashraf, A., Afzal, N., Fani, N., & Reed, L. (2009). Effects of a cognitive stress challenge on myocardial perfusion and plasma cortisol in coronary heart disease patients with depression. Stress and Health, 25, 267–278.
Bruegger-Andersen, T., Poenitz, V., Staines, H., Pritchard, D., Grundt, H., & Nilsen, D. W. T. (2008). B-type natriuretic peptide is a long-term predictor of all-cause mortality, whereas high-sensitive C-reactive protein predicts recurrent short-term troponin T positive cardiac events in chest pain patients: A prognostic study. BMC Cardiovascular Disorders, 8, 34.
Capuron, L., & Miller, A. H. (2011). Immune system to brain signaling: Neuropsychopharmacological implications. Pharmacology & Therapeutics, 130, 226–238.
Carney, R. M., Freedland, K. E., Miller, G. E., & Jaffe, A. S. (2002). Depression as a risk factor for cardiac mortality and morbidity: A review of potential mechanisms. Journal of Psychosomatic Research, 53, 897–902.
Carroll, B. J., Curtis, G. C., & Mendels, J. (1976a). Limbic system-adrenal cortex regulation in depression and schizophrenia. Psychosomatic Medicine, 38, 106.
Carroll, B. J., Curtis, G. C., & Mendels, J. (1976b). Neuroendocrine regulation in depression: Limbic system-adrenocortical dysfunction. Archives of General Psychiatry, 33, 1–30.
Chida, Y., & Steptoe, A. (2009). The association of anger and hostility with future coronary heart disease: A meta-analytic review of prospective evidence. Journal of American College of Cardiology, 53, 936–946.
Cremeans-Smith, J. K., Soehlen, S., Greene, K., Alexander, T., & Delahanty, D. L. (2009). In-hospital levels of C-reactive protein and IL-6 predict post-operative depressive symptoms among patients undergoing total knee replacement surgery. Brain, Behavioral, and Immunity, 23, 1096–1103.
Czarkowska-Paczek, B., Bartlomiejczyk, I., Gabrys, T., Przybylski, J., Nowak, M., & Paczek, L. (2005). Lack of relationship between interleukin-6 and CRP levels in healthy male athletes. Immunology Letters, 99, 136–140.
Denollet, J., & Kupper, N. (2007). Type-D personality, depression, and cardiac prognosis: Cortisol dysregulation as a mediating mechanism. Journal of Psychosomatic Research, 62, 607–609.
Derogatis, L. R. (1994). The SCL-90-R: Administration, scoring and procedures manual. Baltimore, MD: Clinical Psychometric Research.
Eaker, E. D., Sullivan, L. M., Kelly-Hayes, M., D’Agostino, R. B., Sr, & Benjamin, E. J. (2005). Tension and anxiety and the prediction of the 10-year incidence of coronary heart disease, atrial fibrillation, and total mortality: The Framingham Offspring Study. Psychosomatic Medicine, 67, 692–696.
Elenkov, I. J. (2008). Neurohormonal-cytokine interactions: Implications for inflammation, common human diseases and well-being. Neurochemistry International, 52, 40–51.
Elenkov, I. J., & Chrousos, G. P. (2002). Stress hormones, proinflammatory and anti-inflammatory cytokines, and autoimmunity. Annuls of New York Academy of Science, 966, 290–303.
Elzinga, B. M., Schmahl, C. G., Vermetten, E., van Dyck, R., & Bremner, J. D. (2003). Higher cortisol levels following exposure to traumatic reminders in abuse-related PTSD. Neuropsychopharmacology, 28, 1656–1665.
ENRICHD Investigators. (2003). Effects of treating depression and low perceived social support on clinical events after -myocardial infarction: The enhancing recovery in coronary heart disease patients (ENRICHD) randomized trial. JAMA, 289, 3106–3116.
Frasure-Smith, N., & Lespérance, F. (2006). Recent evidence linking coronary heart disease and depression. Canadian Journal of Psychiatry, 51, 730–737.
Ghiadoni, L., Donald, A. E., Cropley, M., Mullen, M. J., Oakley, G., & Taylor, M. (2000). Mental stress induces transient endothelial dysfunction in humans. Circulation, 102, 2473–2478.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009). Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis. Psychosomatic Medicine, 71, 171–186.
Hoyer, J., Eifert, G. H., Einsle, F., Zimmermann, K., Krauss, S., Knaut, M., et al. (2008). Heart-focused anxiety before and after cardiac surgery. Journal of Psychosomatic Research, 64, 291–297.
Kathol, R. G., Jaeckle, R. S., Lopez, J. F., & Meller, W. H. (1989). Pathophysiology of HPA axis abnormalities in patients with major depression: An update. American Journal of Psychiatry, 146, 311–317.
Kiecolt-Glaser, J. K., Preacher, K. J., MacCallum, R. C., Atkinson, C., Malarkey, W. B., & Glaser, R. (2003). Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proceedings of the National Academy of Sciences of the United States of America, 100, 9090–9095.
Kronfol, Z., & Remick, D. G. (2000). Cytokines and the brain: Implications for clinical psychiatry. American Journal of Psychiatry, 157, 683–694.
Lespérance, F., Frasure-Smith, N., Koszycki, D., Laliberte, M., van Zyl, L. T., & Baker, B. (2007). Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: The Canadian cardiac pandomized evaluation of antidepressant and psychotherapy efficacy. JAMA, 297, 367–379.
Lichtman, J. H., Bigger, T., Jr., Blumenthal, J. A., Frasure-Smith, N., Kaufmann, P. G., & Lespérance, F. (2008). Depression and coronary heart disease: Recommendations for screening, referral, and treatment: A science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: Endorsed by the American Psychiatric Association. Circulation, 118, 1768–1775.
Licinio, Z., & Wong, M. L. (1997). Pathways and mechanisms for cytokine signaling of the central nervous system. Journal of Clinical Investigation, 100, 2941–2947.
Lisak, R. P., Benjamins, J. A., Bealmear, B., Nedelkoska, L., Studzinski, D., & Retland, E. (2009). Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures. Journal of Neuroinflammation, 6, 1–27.
Marsland, A., Gianaros, P. J., Abramwitch, S. M., Manuch, S. B., & Hariri, B. R. (2008a). Interleukin-6 covaries inversely with hippocampal gray matter volume in middle-aged adults. Biopsych, 64, 484–490.
Marsland, A., Prather, A. A., Petersen, K. L., Cohen, S., & Manuck, S. B. (2008b). Antagonistic characteristics are positively associated with inflammatory markers independently of trait negative emotionality. Brain, Behavior, and Immunity, 22, 753–761.
Martens, E. J., Kupper, N., Pedersen, S. S., Aquarius, A. E., & Denollet, J. (2007). Type-D personality is a stable taxonomy in post-MI patients over an 18-month period. Journal of Psychosomatic Research, 63, 545–550.
Miller, G. E., & Blackwell, E. (2006). Turning up the heat: Inflammation as a mechanism linking chronic stress, depression, and heart disease. Current Directions in Psychological Science, 15, 269–272.
Mosovich, S. A., Boone, R. T., Reichenberg, A., Bansilal, S., Shaffer, J., & Dahlman, K. (2008). New insights into the link between cardiovascular disease and depression. International Journal of Clinical Practice, 62, 423–432.
Nemeroff, C. B. (1996). The corticotropin-releasing factor (CRF) hypothesis of depression: New findings and new directions. Molecular Psychiatry, 1, 336–342.
Niaura, R., Todaro, J. F., Stroud, L., Ward, K., Spiro, A., I. I. I., & Weiss, S. (2002). Hostility, the metabolic syndrome, and incident coronary heart disease. Health Psychology, 21, 588–593.
Nikisch, G. (2009). Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function. Neuroendocrinology Letters, 30, 11–16.
Otte, C., Marmar, C. R., Pipkin, S. S., Moos, R., Browner, W. S., & Whooley, M. A. (2004). Depression and 24-hour urinary cortisol in medical outpatients with coronary heart disease: The heart and soul study. Biological Psychiatry, 56, 241–247.
Pargament, K. I., Koenig, H. G., & Perez, L. M. (2000). The many methods of religious coping: Development and initial validation of the RCOPE. Journal of Clinical Psychology, 56, 519–543.
Pariante, C. M., & Miller, A. H. (2001). Glucocorticoid receptors in major depression: Relevance to pathophysiology and treatment. Biological Psychiatry, 49, 391–404.
Pasic, J., Levy, W. C., & Sullivan, M. D. (2003). Cytokines in depression and heart failure. Psychosomatic Medicine, 65, 181–193.
Payne, L. C., Weigent, D. A., & Blalock, J. E. (1994). Induction of pituitary sensitivity to interleukin-1: A new function for corticotropin-releasing hormone. Biochemical and Biophysical Research Communications, 198, 480–484.
Pignay-Demaria, V., Lesperance, F., Demaria, R. G., Frasure-Smith, N., & Perrault, L. P. (2003). Depression and anxiety and outcomes of coronary artery bypass surgery. Annals of Thoracic Surgery, 75, 314–321.
Plaschke, K., Fichtenkamm, P., Schramm, C., Hauth, S., Martin, E., & Verch, M. (2010). Early postoperative delirium after open-heart cardiac surgery is associated with decreased bispectral EEG and increased cortisol and interleukin-6. Intensive Care Medicine, 36, 2081–2089.
Raber, J., Sorg, O., Horn, T. F., Yu, N., Koob, G. F., Campbell, I. L., et al. (1998). Inflammatory cytokines: Putative regulators of neuronal and neuro-endocrine function. Brain Research Review, 26, 320–326.
Radley, J. J., Kabbaj, M., Jacobson, L., Heydendael, W., Yehuda, R., & Herman, J. P. (2011). Stress risk factors and stress-related pathology: Neuroplasticity, epigenetics and endophenotypes. Stress, 14, 481–497.
Refojo, D., & Holsboer, F. (2009). CRH signaling: Molecular specificity for drug targeting in the CNS. Annals of the New York Academy of Sciences, 1179, 106–119.
Ridker, P. M. (2003a). High-sensitivity C-reactive protein and cardiovascular risk: Rationale for screening and primary prevention. American Journal of Cardiology, 92, 17K–22K.
Ridker, P. M. (2003b). Connecting the role of C-reactive protein and statins in cardiovascular disease. Clinical Cardiology, 26, III39–III44
Riechlin, S. (1993). Neuroendocrine-immune interactions. New England Journal of Medicine, 329, 3–5.
Rifai, N., & Ridker, P. M. (2003). Population distributions of C-reactive protein in apparently healthy men and women in the United States: Implication for clinical interpretation. Clinical Chemistry, 49, 666–669.
Rothenbacher, D., Hahmann, H., Wusten, B., Koenig, W., & Brenner, H. (2007). Symptoms of anxiety and depression in patients with stable coronary heart disease: Prognostic value and consideration of pathogenetic links. European Journal of Cardiovascular Preventation & Rehabilitation, 14, 547–554.
Scheidt, S. (2000). The current status of heart-mind relationships. Journal of Psychosomatic Research, 48, 317–320.
Segerstrom, S. C., & Miller, G. E. (2004). Psychological stress and the human immune system: A meta-analytic study of 30 years of inquiry. Psychological Bulletin, 130, 601–630.
Shaffer, J. A., Edmondson, D., Chaplin, W. F., Schwartz, J. E., Shimbo, D., & Burg, M. M. (2011). Directionality of the relationship between depressive symptom dimensions and C-reactive protein in patients with acute coronary syndromes. Psychosomatic Medicine, 73, 370–377.
Sherwood, A., Blumenthal, J. A., Trivedi, R., Johnson, K. S., O’Connor, C. M., Adams, K. F., Jr., et al. (2007). Relation of depression to death or hospitalization in patients with heart failure. Archives of Internal Medicine, 167, 367–373.
Snyder, C. R., Harris, C., Anderson, J. R., Holleran, S. A., Irving, L. M., & Sigmon, S. (1991). The will and the ways: Development and validation of an individual-differences measure of hope. Journal of Personality and Social Psychology, 60, 570–585.
Spielberger, C. D. (1983). Manual for the state-trait anxiety inventory (Form Y: Self-evaluation questionnaires). Palo Alto, CA: Consulting Psychologists Press.
Troxler, R. G., Sprague, E. A., Albanese, R. A., Fuchs, R., & Thompson, A. J. (1977). The association of elevated plasma cortisol and early atherosclerosis as demonstrated by coronary angiography. Atherosclerosis, 26, 151–162.
Van der Kooy, K., van Hout, H., Marwijk, H., Marten, H., Stehouwer, C., & Beekman, A. (2007). Depression and the risk for cardiovascular diseases: Systematic review and meta-analysis. International Journal of Geriatric Psychiatry, 22, 613–626.
Veen, G., Giltay, E. J., van Vliet, I. M., DeRijk, R. H., Klaassens, E. R., van Pelt, J., et al. (2011). C-reactive protein polymorphisms are associated with the cortisol awakening response in basal conditions in human subjects. Stress, 14, 128–135.
W. H. O. Study. (1987). The dexamethasone suppression test in depression. British Journal of Psychiatry, 150, 459–462.
Whitehead, D. L., Perkins-Porras, L., Strike, P. C., Magid, K., & Steptoe, A. (2007). Cortisol awakening response is elevated in acute coronary syndrome patients with type-D personality. Journal of Psychosomatic Research, 62, 419–425.
Wieczorek, M. (2009). Various aspects of IL-1 biological activity. II. IL-1 beta in diseases and the central nervous system. Wiadomosci Parazytologiczne, 55, 115–124.
Wills, T. A. (1996). An Analysis of downward comparison in the structure of other cognitive and behavior mechanisms. In: B. P. Bunk & F. X. Gibbons (Eds.), Health, coping, and well-being. Mahwah, NJ: Lawrence Erlbaum. (Sara, this one is the 67 not Neter et al.)
Ziegelstein, R. (2001). Depression in patients recovering from a myocardial infarction. JAMA, 286, 1621–1627.
Zimet, G. D. (1988). The multidimensional scale of perceived social support. Journal of Personality Assessment, 52, 30–41.
Zunszain, P. A., Anacker, C., Cattaneo, A., Carvalho, L. A., & Pariante, C. M. (2011). Glucocorticoids, cytokines and brain abnormalities in depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35, 722–729.
Acknowledgments
This work was supported by National Institute on Aging Grant 1 R03 AG15686-01, National Center for Complementary and Alternative Medicine Grant P50 AT00011, and Grants from the John Templeton Foundation and Hartford Geriatric Faculty Scholars Program. The opinions expressed in this article are those of the authors and do not necessarily reflect the views of these organizations.
Conflict of interest
There is no conflict of interest in the manuscript, including financial, consultant, institutional and other and other relationships that might lead to bias in this paper.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ai, A.L., Kabbaj, M. & Kathy, L.L. Body affects mind? Preoperative behavioral and biological predictors for postoperative symptoms in mental health. J Behav Med 37, 289–299 (2014). https://doi.org/10.1007/s10865-012-9484-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10865-012-9484-3